Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report
Rhea-AI Summary
Progyny (Nasdaq: PGNY) will report fourth quarter and full year 2025 results after market close on February 26, 2026.
The company will host a conference call at 4:45 p.m. ET and publish a press release before the call. Dial‑in numbers, passcode 265484, replay through March 5, 2026, and a live webcast/archive are available on the investor website.
Positive
- None.
Negative
- None.
News Market Reaction – PGNY
On the day this news was published, PGNY declined 2.65%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
PGNY is nearly flat (+0.14%) while healthcare plan peers in the momentum list such as MOH (+4.1200000792741776%) and OSCR (+4.1200000792741776%) show stronger upside, pointing to a stock-specific, low-impact reaction to this scheduling announcement.
Previous Earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 06 | Q3 2025 results | Positive | -4.6% | Reported Q3 2025 growth, strong cash flow, raised full-year 2025 guidance. |
| Oct 23 | Q3 call details | Neutral | +1.7% | Announced Q3 2025 earnings release date and conference call logistics. |
| Aug 07 | Q2 2025 results | Positive | -0.9% | Delivered strong Q2 2025 revenue and earnings, raised full-year guidance. |
| Jul 08 | Q2 update & date | Positive | +13.2% | Secured $200M credit facility and guided Q2 results above prior expectations. |
| May 08 | Q1 2025 results | Positive | -9.3% | Posted record Q1 2025 revenue, margin expansion, and raised 2025 guidance. |
Across recent earnings-related headlines, strong fundamental results and raised guidance often coincided with negative or mixed next-day moves, while pre-announcement logistics updates sometimes saw modest gains.
Over 2025, Progyny reported steadily growing revenue and profitability in Q1–Q3 2025, repeatedly raising full-year 2025 guidance and highlighting strong cash flow, expanding client counts, and share repurchase authorizations. Despite fundamentally strong quarters, next-day stock reactions to results on May 8, Aug 7, and Nov 6 were negative or muted. By contrast, business updates and earnings date announcements on Jul 8 and Oct 23 drew positive responses. Today’s notice fits the pattern of logistical updates preceding detailed financial releases.
Historical Comparison
In the past year, PGNY issued multiple earnings and pre-earnings updates. Price reactions around these events averaged near 0%, with strong fundamentals not always translating into upside.
Earnings updates in 2025 showed progression from strong Q1 results through Q3, with repeated full-year 2025 guidance raises, increased client counts, and added financial flexibility via a revolving credit facility.
Market Pulse Summary
This announcement schedules Progyny’s report of Q4 and full-year 2025 results and details how investors can access the call and replay. In context of 2025, prior quarters showed revenue growth, raised guidance, and active capital management, while market reactions were sometimes inconsistent with fundamentals. Investors may focus on how full-year figures compare to earlier guidance updates, cash generation, and any changes in client growth or repurchase activity when the results are released.
AI-generated analysis. Not financial advice.
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026.
The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Thursday, March 5, 2026, and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
When will Progyny (PGNY) release Q4 and full year 2025 results?
What time is the PGNY earnings conference call on February 26, 2026?
How can investors join the Progyny (PGNY) earnings call and webcast?
Will there be a replay of the PGNY February 26, 2026 earnings call?
Where can I find the Progyny (PGNY) webcast and archived presentation for the 2025 results?
